AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Vienna hosts 720 at Global Peter Drucker Forum on innovation and leadership
AGP
The 18th Global Peter Drucker Forum brings about 720 participants from 65 countries to Vienna on Nov. 4-5 to examine how creativity, innovation and leadership will shape organizations.
Kymriah market seen growing on CAR-T demand and personalized medicine
AGP
The Business Research Company says the global Kymriah market is expanding on stronger clinical adoption, rising blood cancer cases and broader interest in personalized cancer care.
Kepivance market forecast points to steady growth through 2035
AGP
The Business Research Company says the global Kepivance market is set to expand through 2035 as cancer treatment volumes rise, stem cell transplants increase and supportive oncology care gains priority.
Kimmtrak market outlook points to growth through 2035
AGP
The Business Research Company says the global Kimmtrak market is gaining momentum as uveal melanoma cases rise, the patient population ages, and immunotherapy expands.
BPH treatment market seen reaching $11.29 billion by 2030
AGP
The benign prostatic hyperplasia treatment market is projected to grow from $8.69 billion in 2025 to $11.29 billion by 2030, driven by aging populations, wider use of minimally invasive procedures and more personalized care.
Megatope market forecast improves as cancer demand rises
AGP
The Business Research Company says the global megatope market is set for stronger growth through 2035, driven by rising cancer incidence, higher healthcare spending and expanding interest in personalized immunotherapies.
France and Italy join 2026 Global Mayors Dialogue in Ningbo
AGP
Officials from 15 countries met in Ningbo, China, from Nov. 2 to 5 for the 2026 Global Mayors Dialogue, where cities signed 14 cooperation projects and released a new development consensus.
BCMA targeted therapies market seen reaching $44.29 billion by 2030
AGP
The market for B-cell maturation antigen targeted therapies is projected to jump from $15.09 billion in 2025 to $18.75 billion in 2026, driven by multiple myeloma demand and faster adoption of next-generation immunotherapies.
Lunsumio market seen growing on rising blood cancer cases
AGP
The Business Research Company says the global market for Lunsumio, a bispecific antibody therapy for relapsed or refractory follicular lymphoma, is set to expand through 2035 as cancer treatment shifts toward personalized immuno-oncology.
Evkeeza market set for growth on genetic screening and rare disease demand
AGP
The Business Research Company says the Evkeeza market is positioned for steady expansion through 2035 as genetic screening, biologic adoption and reimbursement for rare diseases improve access to treatment.
Evicel market seen growing on surgical demand and bleeding disorder cases
AGP
The Business Research Company says the Evicel market is set for long-term growth through 2035, driven by rising surgical volumes, more bleeding disorders and wider use of hemostatic agents.
Evithrom market report forecasts growth through 2035
AGP
The Business Research Company says the global Evithrom market is poised for growth through 2035, driven by more surgeries, trauma cases, and broader use of human thrombin products in bleeding control.
BCL-2 inhibitors market seen topping $5.39 billion by 2030
AGP
The Business Research Company says the global BCL-2 inhibitors market is set to climb from $2.46 billion in 2025 to $2.89 billion in 2026, then reach $5.39 billion by 2030. The report points to rising blood cancer cases, wider use of venetoclax…
Evenity market seen growing on osteoporosis demand and better screening
AGP
The Business Research Company says the Evenity market is set for steady growth as osteoporosis rates rise, especially among postmenopausal women at fracture risk.
Malou Beauvoir releases second OUR VODOU children's book
AGP
Malou Beauvoir has released the second book in her OUR VODOU children’s series, expanding a multilingual project that introduces young readers to Haitian history, ancestral traditions and cultural pride.
Basal cell carcinoma treatment market seen reaching $13 billion by 2030
AGP
The global basal cell carcinoma treatment market is forecast to rise from $8.87 billion in 2026 to $13.03 billion by 2030, according to The Business Research Company.
Atrophic glossitis treatment market seen reaching $2.71 billion by 2030
AGP
The global atrophic glossitis treatment market was valued at $1.88 billion in 2025 and is forecast to reach $2.71 billion by 2030, driven by rising nutritional deficiencies, autoimmune disease cases and broader access to diagnosis and care.
Leukine market seen growing on cancer care demand
AGP
The Business Research Company says the global Leukine market is set to expand through 2026 as cancer treatments, supportive care and immune recovery needs rise.
Barrett's esophagus market seen reaching $9.52 billion by 2030
AGP
The Barrett’s esophagus market is forecast to grow from $6.71 billion in 2025 to $9.52 billion by 2030, driven by wider use of advanced endoscopic imaging, precision ablation therapies and earlier intervention.
Autoimmune diagnosis market seen rising to $9.38 billion by 2030
AGP
The autoimmune disease diagnosis market is projected to climb from $6.2 billion in 2025 to $6.74 billion in 2026, with further growth expected through 2030. The Business Research Company says rising autoimmune prevalence, higher healthcare…
Sign up for:
Africa News Guide
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.